Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Fruquintinib Plus Everolimus as 2nd Line Therapy of ccRCC Patients Progressed Post IO and TKI Therapy

Peking University First Hospital · 2024
ClinicalTrials.gov · Datasets · License: Public Domain · 2024
Open Source ↗
narenal-cell-carcinoma
renal cell carcinoma, clear cell, somatic, fruquintinib, everolimus, interventional, na
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 1045475
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.